Randomized trials of aminoglycoside antibiotics: quantitative overview.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Reviews of Infectious Diseases

• Publication date

  1988-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CLINIDS/10.5.951PMID 3055193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Implications of overviews of randomized trials.

  1987cited by this paper
• Qualitative overview of randomized trials of aminoglycosides.

  1986cited by this paper
• A Comparative Study of Gentamicin and Netilmicin in the Treatment of Gram-Negative Infections

  1985cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.

  1984cited by this paper
• Netilmicin versus tobramycin in multi-centre studies.

  1984cited by this paper
• Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin

  1984cited by this paper
• Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin

  1983cited by this paper
• Controlled comparison of gentamicin and tobramycin nephrotoxicity.

  1983cited by this paper
• A comparative study of netilmicin-cefoxitin and gentamicin-cefoxitin in surgical patients with serious systemic infection.

  1983cited by this paper
• Randomised, controlled trial of the comparative efficacy, auditory toxicity, and nephrotoxicity of tobramycin and netilmicin.

  1983cited by this paper
• A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC.

  1983cited by this paper
• Aminoglycoside nephrotoxicity: a double blind prospective randomized study of gentamicin and tobramycin.

  1982cited by this paper
• Minimal nephrotoxicity with cephalosporin-aminoglycoside combinations in patients with neoplastic disease

  1982cited by this paper
• Prospective double-blind controlled clinical study of sisomicin versus tobramycin.

  1981cited by this paper
• Tobramycin versus Gentamicin, in Combination with Cephalotin and Carbenecillin, in Patients Undergoing Bone Marrow Transplantation

  1981cited by this paper
• Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study.

  1981cited by this paper
• Prospective double-blind controlled clinical study of sisomicin versus tobramycin.

  1981cited by this paper
• Multicenter comparative evaluation of netilmicin and gentamicin in adult patients. Efficacy and safety.

  1981cited by this paper
• Comparative clinical trial of sisomicin and gentamicin in serious systemic gram-negative infections.

  1981cited by this paper
• Renal toxicity during therapy with gentamicin or tobramycin.

  1981cited by this paper
• Comparison of sisomicin and gentamicin in the treatment of serious systemic infections.

  1980cited by this paper
• Prospective comparative study of efficacy and toxicity of netilmicin and amikacin

  1980cited by this paper
• Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity

  1980cited by this paper
• Comparison of sisomicin and gentamicin in the treatment of serious systemic infections

  1980cited by this paper
• Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.

  1980cited by this paper
• Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.

  1979cited by this paper
• A Randomized Comparative Trial of Three Aminoglycosides—Comparison of Continuous Infusions of Gentamicin, Aaikacin and Sisomicin Combined with Carbenicillin in the Treatment of Infections in Neutropenic Patients with Malignancies

  1979cited by this paper
• A Comparison of Netilmicin and Gentamicin in the Treatment of Pelvic Infections

  1979cited by this paper
• Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside.

  1978cited by this paper
• Comparison of Netilmicin and Amikacin in Treatment of Complicated Urinary Tract Infections

  1978cited by this paper
• A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.

  1978cited by this paper
• Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.

  1977cited by this paper
• Comparison of amikacin and gentamicin in the treatment of urinary tract infections.

  1977cited by this paper
• Controlled comparison of amikacin and gentamicin.

  1977cited by this paper
• Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.

  1977cited by this paper
• Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin.

  1977cited by this paper
• Comparison of tobramycin and gentamicin in the treatment of complicated urinary tract infections.

  1976cited by this paper
• A randomized, comparative study of tobramycin and gentamicin in treatment of acute urinary tract infections.

  1976cited by this paper
• Feasibility of Administering Aminoglycoside Antibiotics by Continuous Intravenous Infusion

  1975cited by this paper
• Comparison of Sisomicin and Gentamicin in Bacteriuric Patients with Underlying Diseases of the Urinary Tract

  1975cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic Strategies

  2025cites this paper
• Simplified Dosing Regimens for Gentamicin in Neonatal Sepsis

  2021cites this paper
• DEVELOPMENT AND VALIDATION OF A SEMI-PHYSIOLOGICAL PHARMACOKINETIC (PBPK) MODEL TO PREDICT SYSTEMIC AND PULMONARY EXPOSURES AFTER INTRAVENOUS, ORAL ADMINISTRATION AND PULMONARY INHALATION OF SELECTED DRUGS, BUDESONIDE, TOBRAMYCIN AND CIPROFLOXACIN, IN HUMANS

  2018cites this paper
• Role of Chemical Entities in Ototoxicity

  2018cites this paper
• Aminoglycoside-induced nephrotoxicity in children

  2016cites this paper
• Rational use of aminoglycosides—Review and recommendations by the Swedish Reference Group for Antibiotics (SRGA)

  2013cites this paper
• Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis

  2010cites this paper
• Side effects of aminoglycosides on the kidney , ear and balance in cystic fibrosis

  2010cites this paper
• AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.

  2009cites this paper
• Shifts in auditory brainstem response latencies following plasma-level-controlled aminoglycoside therapy

  2004cites this paper
• Infections in patients undergoing peritoneal dialysis.

  2001cites this paper
• Adult Peritoneal Dialysis-Related Peritonitis Treatment Recommendations: 2000 Update

  2000cites this paper
• Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.

  1999cites this paper
• Peritonitis in Paediatric Continuous Peritoneal Dialysis

  1998cites this paper
• Drug administration in intermittent renal replacement therapy

  1998cites this paper
• Use of Aminoglycosides in Elderly Patients

  1997cites this paper
• Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update.

  1996cites this paper
• Reviews and Original Articles

  1996cites this paper
• Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis

  1995influential citation
• Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial.

  1995cites this paper
• Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis

  1994cites this paper
• Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial.

  1994cites this paper
• Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis.

  1993cites this paper
• Treatment Recommendations 1993 Update

  1993cites this paper
• Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children

  1992cites this paper
• Toxicities of antimicrobial agents used to treat osteomyelitis.

  1991cites this paper
• Pharmacokinetic evaluation of single daily dose amikacin.

  1991cites this paper
• Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection

  1991cites this paper
• [Comparison of netilmicin administration once or three times daily in intensive care patients].

  1991cites this paper
• Pharmacodynamic Parameters andToxicity ofNetilmicin (6Milligrams/Kilog ram/Day) GivenOnceDaily orinThreeDivided DosestoCancerPatients withUrinary TractInfection

  1991cites this paper
• Aminoglycoside induced ototoxicity in patients with cystic fibrosis

  1991cites this paper
• Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections

  1990cites this paper
• Aminoglycoside-induced ototoxicity.

  1990cites this paper
• Netilmicin

  1989cites this paper
• Continuous ambulatory peritoneal dialysis (CAPD) peritonitis treatment recommendations: 1989 update. The Ad Hoc Advisory Committee on Peritonitis Management.

  1989cites this paper
• Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

  1989cites this paper
• Meta‐Analysis: Whither Narrative Review?

  1989cites this paper